Biotechnology Analysts Stavropoulos, Schimmer & Schmidt, along with Dr. Chee Kay Cheung, Nephrologist at University Hospitals of Leicester NHS Trust, discuss emerging therapies for autoimmune kidney diseases (relevant company VERA) on an Analyst/Industry conference call to be held on January 18 at 10 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VERA:
- Vera Therapeutics appoints Robert Brenner as CMO, William Turner as CDO
- Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer
- Vera Therapeutics initiated with an Overweight at Cantor Fitzgerald
- Best Stock to Buy Today, 12/28/2023, According to Top Analysts
- H.C. Wainwright estimates Vera’s cash runway now extends into Q2 2026